Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma

Archives of Surgery

Volumn 144, Issue 1, 2009, Pages 46-51

  Ishizawa, Takeaki ^a   Hasegawa, Kiyoshi ^a   Kokudo, Norihiro ^a   Sano, Keiji ^a   Imamura, Hiroshi ^a   Beck, Yoshifumi ^a   Sugawara, Yasuhiko ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANRENOATE POTASSIUM; FRESH FROZEN PLASMA; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ASCITES; BLEEDING; BODY WEIGHT; FEMALE; HOSPITAL COST; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PLASMA TRANSFUSION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY; THROMBOCYTE COUNT; URINE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 58749110682     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2008.511     Document Type: Article

References (35)

1. Fuster J, Gracía-Valdecasas JC, Luis G, et al. Hepatocellular carcinoma and cirrhosis: results of surgical treatment in a European series. Ann Surg. 1996;223(3):297-302.
2. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229(6):790-800.
3. Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? a prospective analysis of our approach. Arch Surg. 1999;134(9):984-992.
4. Belghiti J, Hiramatsu K, Benoist S, Massault PP, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191(1):38-46.
5. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234(1):71-78.
6. Lang BH, Poon RT, Fan ST, Wong J. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg. 2003;138(11):1207-1213.
7. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321-328.
8. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993;218(2):145-151.
9. Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003;237(4):536-543.
10. Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003;237(5):686-693.
11. Liu CL, Fan ST, Lo CM, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg. 2004;239(2):194-201.
12. Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg. 1999;134(10):1124-1130.
13. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236(4):397-407.
14. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9(4):298-304.
15. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169(6):589-594.
16. Imamura H, Seyama Y, Kokudo N, et al. One thousand forty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138(11):1198-1206.
17. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology. 1997;26(5):1176-1181.
18. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985;161(4):346-350.
19. Takayama T, Makuuchi M, Kubota K, et al. Radomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg. 2001;136(8):922-928.
20. Arita J, Hasegawa K, Kokudo N, Sano K, Sugawara Y, Makuuchi M. Randomised clinical trial of the effect of a saline-linked radiofrequency coagulator on blood loss during hepatic resection. Br J Surg. 2005;92(8):954-959.
21. Edelman I, Leibman J. Anatomy of body water and electrolytes. AmJMed. 1959;27(2):256-277.
22. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis, III: multivariate data analysis and assessing its adequacy and fit. Br J Cancer. 2003;89(4):605-611.
23. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258-266.
24. Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996;23(1):164-176.
25. Ginès P, Cárdenas A, Arroyo V, Rodés J. Management of cirrhosis and ascites. N Engl J Med. 2004;350(16):1646-1654.
26. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329-338.
27. Buerk CA, Putnam CW, Starzl TE. Major hepatic resection and portal pressure. Surg Gynecol Obstet. 1977;144(6):853-854.
28. Kanematsu T, Takenaka K, Furuta T, Ezaki T, Sugimachi K, Inokuchi K. Acute portal hypertension associated with liver regeneration: analysis of early postoperative death. Arch Surg. 1985;120(11):1303-1305.
29. Lee SS, Hadengue A, Moreau R, Sayegh R, Hillon P, Lebrec D. Postprandial hemodynamic responses in patients with cirrhosis. Hepatology. 1988;8(3):647-651.
30. Gaiani S, Bolondi L, Bassi S, Santi V, Zironi G, Barbara L. Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology. 1989;9(6):815-819.
31. Ginès P, Titó L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988;94(6):1493-1502.
32. Ginès A, Fernández-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111(4):1002-1010.
33. Caldwell SH, Hoffman M, Lisman T, et al; Coagulation in Liver Disease Group. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44(4):1039-1046.
34. Andreu G, Morel P, Forestier F, et al. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 2002;42(10):1356-1364.
35. Norda R, Tynell E, Akerblom O. Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe. J Trauma. 2006;60(6)(suppl):S41-S45.